MEDICAL CANNABIS COST AUSTRALIA
Medical Cannabis Cost Australia: Consultation Fees, Medication Prices & Total Treatment Cost
The advertised consultation fee is only one part of the real cost of medicinal cannabis care. This guide breaks down the clinical, medication and recurring costs so you can compare providers on the total treatment pathway—not one headline number.
What actually makes up the total cost?
There is no single universal price for medicinal cannabis treatment in Australia. The amount a person spends can change with the type of clinical service, how often reviews are needed, the medicine prescribed, dose, dispensing arrangements and delivery where applicable.
Initial assessment, reviews and repeat-prescription consultations where applicable
The pharmacy-supplied medicine and any dispensing or delivery charges
How often each of those costs recurs over time
That is why comparing clinics by the first appointment fee alone can be misleading. A low entry price may still sit inside a higher ongoing-cost pathway, while a higher consultation fee does not automatically mean the overall treatment pathway is more expensive.
Six cost components patients should separate
Think of each cost as a different line item. Keeping them separate makes provider comparisons far more useful.
Why a $0 consultation does not mean $0 treatment
A $0 consultation tells you the price of one component—not the price of treatment.
Some services may subsidise or waive an initial consultation as part of a different commercial model. That is not automatically good or bad. The important question is what the patient may pay across the whole pathway: reviews, repeat prescribing, medication, dispensing, delivery and any membership or recurring fees.
The reverse is also true. A clinic with a clearly priced consultation is not automatically more expensive overall. The only meaningful comparison is the complete expected cost of care.
Why do medicinal cannabis clinics use different pricing models?
Australian clinics can structure their services differently. None of the following models is automatically superior; transparency and clinical independence matter more than the label.
How to compare two clinics properly
| Cost to understand | Clinic A | Clinic B |
|---|---|---|
| Initial consultation | Advertised clearly | Advertised clearly |
| Follow-up consultations | Check provider | Check provider |
| Repeat-prescription fee | Check provider | Check provider |
| Medication / dispensing | Check provider | Check provider |
| Delivery or membership | Check provider | Check provider |
| Frequency of reviews | Check provider | Check provider |
| Estimated ongoing cost | Cannot be known from the first row | Cannot be known from the first row |
The cheapest number in the first row does not establish the cheapest treatment pathway. If an advertised price does not show the other components, ask the provider before comparing. A fair comparison looks at what each component costs and how often it is likely to recur.
Why cost transparency matters
What Australian research says about cost and consumer vulnerability
A 2025 peer-reviewed Australian qualitative study by Gething, Erku and Scuffham analysed 60 consumer submissions to a Senate inquiry into barriers to medicinal cannabis access. Within that submission sample, the authors identified cost among the barriers affecting access and described how limited consumer control and market conditions can contribute to vulnerability.
The lesson for a pricing page is not that one clinic model is automatically wrong. It is that patients benefit from being able to understand the complete financial pathway before committing to care.
Source: Gething K, Erku D, Scuffham P. Medicinal Cannabis and Consumer Vulnerability in Australia: A Nexus of Policy and Market Factors. Health Expectations. 2025;28:e70176. View the peer-reviewed article.
Healthdirect notes that medicinal cannabis costs can vary substantially and may amount to thousands of dollars per year depending on the product and dose. This reinforces why patients should think in terms of ongoing treatment cost rather than an isolated consultation fee. Healthdirect: Medicinal cannabis. External cost and subsidy information should be checked at the time of treatment because prices, fees and subsidy arrangements can change.
Seven questions to ask before choosing a clinic
You do not need to interrogate a clinic like an accountant. These seven questions are enough to reveal whether the pricing model is understandable.
- What does the initial consultation cost? Know exactly what is included in the assessment fee.
- How often are follow-up reviews normally required? Frequency can matter as much as the individual fee.
- What do follow-up consultations cost? Separate the first appointment from ongoing care.
- Are repeat-prescription consultations charged separately? Ask what triggers a repeat or review fee.
- How are medication and dispensing costs communicated? Medication should not disappear inside a vague “treatment package”.
- Are there membership, subscription or delivery costs? Small recurring fees accumulate over time.
- Does the clinic receive a financial benefit connected with medication supply? The answer helps patients understand how the commercial model works.
A network pharmacy can be about coordination—not commission
Preferred or network pharmacies are not inherently a warning sign. A clinic may recommend a pharmacy because the dispensing team is familiar with its prescription workflow, communication is easier, stock coordination may be smoother, and patients may find the process more convenient.
The relevant pricing question is not simply “Is this a network pharmacy?” It is: How are medication and dispensing costs communicated, and does the clinic receive a financial benefit from the medicine?
That distinction matters for DocTel because DocTel may recommend pharmacies in its network for operational reasons, but the recommendation does not create a medication markup, pharmacy commission or other financial benefit for DocTel.
How DocTel Medicanna's pricing model works
DocTel separates the clinical service from the medication transaction. That distinction makes it easier to see what you are paying for.
DocTel does not add a product markup.
DocTel does not receive a commission from medication supplied by a pharmacy.
DocTel does not receive a financial benefit from pharmacy-supplied medication.
DocTel may recommend a network pharmacy to support efficient prescription processing, communication and dispensing. That recommendation is operational; it is not a medication-sales revenue stream for DocTel.
How to think about cost over three months—not just day one
A useful comparison should look forward. The initial appointment is paid once, but other costs may recur at different intervals. A patient could therefore compare two clinics by mapping the first three months of expected care rather than comparing only the first booking screen.
Start with the initial clinical fee. Then add any scheduled follow-up reviews, repeat-prescription consultations, membership charges, dispensing or delivery fees and the medication cost itself. The result is not a guaranteed forecast—treatment plans can change—but it is a much more realistic way to compare models.
For example, Clinic A might advertise a very low first consultation but require more frequent paid reviews or operate within a structure where other costs are less obvious at the start. Clinic B might charge more for the first clinical assessment but have a simpler ongoing fee structure. Without adding the recurring costs, a patient cannot know which pathway is actually cheaper.
Month 1: initial assessment + medication/dispensing + any delivery or membership cost.
Month 2: medication/dispensing + any scheduled review or recurring fee.
Month 3: medication/dispensing + any review, repeat-prescription or recurring fee.
Then compare the total—not the first transaction.
This also helps patients ask better questions before committing to a service. A clinic that explains likely review frequency, how prescription renewals are handled and where medication charges sit makes it easier for patients to plan financially.
Medication price is not one fixed number
Patients searching for “medical cannabis price Australia” often expect a single product price. In practice, medication cost depends on the prescribed product, quantity, dose and how long a supply lasts. A monthly figure quoted by another patient—or even an average quoted online—may therefore have little relevance to an individual treatment plan.
This is why the page separates clinical fees from medicine costs. The clinician’s consultation is payment for assessment and medical decision-making. The pharmacy transaction is payment for the medicine that is actually prescribed and dispensed. Combining the two into one vague headline can make it difficult to understand which part of the pathway is driving cost.
Healthdirect notes that medicinal cannabis expenditure can vary substantially and may reach thousands of dollars per year depending on the product and dose. That is a better way to understand the market than relying on a single “average monthly price.”
When discussing medication costs, ask practical questions: Is the quoted amount for one pack or a month of treatment? How long is the prescribed quantity expected to last? Are delivery or dispensing charges separate? If the treatment plan changes, will the cost change as well?
Those questions do not interfere with clinical decision-making. They simply allow the patient to understand the financial consequences of the treatment that has actually been prescribed.
Cost is one part of the decision
This page deliberately stays focused on price and financial transparency. Other questions belong to the specialist resources below.
Medical cannabis cost FAQs
How much does medicinal cannabis cost in Australia?
There is no single national price. Costs can include the clinical consultation, follow-up care, repeat-prescription consultations where applicable, medication, dispensing and delivery. Healthdirect notes that medicinal cannabis may cost thousands of dollars per year depending on the product and dose.
How much does a medicinal cannabis consultation cost?
Consultation fees vary between providers and service models. The more useful comparison is not just the initial fee but the total expected cost of clinical care over time, including follow-ups and repeat-prescription care where applicable.
Are $0 medicinal cannabis consultations really free?
A $0 consultation means the consultation itself is priced at $0. It does not mean medication, dispensing, delivery, follow-ups or other recurring services are also free. Patients should compare the complete cost pathway.
Does Medicare cover medicinal cannabis consultations?
Medicare eligibility can depend on the practitioner, service and consultation arrangement. Do not assume a medicinal-cannabis telehealth service is Medicare-funded simply because it is a medical consultation; check the provider’s billing information before booking.
Is medicinal cannabis covered by the PBS?
Most medicinal cannabis is not subsidised through the PBS. Healthdirect notes limited PBS subsidy for a specific medicinal-cannabis medicine used for certain types of epilepsy. Patients should check current PBS information and their own prescription circumstances.
Why can medication prices vary so much?
Medication cost can vary with product, dose, quantity and dispensing arrangements. That is why a clinic’s consultation price alone cannot predict a patient’s total treatment cost.
Does DocTel make money from medicinal cannabis products or pharmacy referrals?
No. DocTel does not add a markup to medicinal cannabis products, does not receive pharmacy commission and does not receive another financial benefit from medication supplied by a pharmacy. DocTel may recommend a network pharmacy for operational coordination and dispensing convenience.
Understand the cost before you choose a clinic
Understand your options. Know where the costs sit. Then decide whether a clinical assessment is right for you.
Paying for a consultation does not guarantee a prescription. Prescribing remains an independent clinical decision.